Key-Whitman Eye Center Selects Nextech
October 08, 2024 14:30 ET
|
Nextech Systems, Inc.
Nextech’s ophthalmology platform has been selected by Key-Whitman Eye Center to serve its multiple locations in the Dallas-Fort Worth metroplex.
Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
July 30, 2024 08:00 ET
|
Smith & Nephew UK Ltd
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces an exclusive digital and advanced analytics collaboration with Healthcare Outcomes Performance Company (HOPCo) –...
ZyVersa Therapeutics Announces Publication Demonstrating that Inflammasome ASC Inhibitor IC 100 Restored Retinal Structure and Function in a Retinopathy of Prematurity Animal Model
July 18, 2024 11:18 ET
|
ZyVersa Therapeutics
Inflammasome ASC Inhibitor IC 100 Reduced Inflammation and Restored Retinal Structure and Function in Retinopathy of Prematurity Animal Model
Virtus Diversified REIT Announces Pending Acquisition of Multi-Residential Apartment Building in Parry Sound, Ontario
October 30, 2023 08:30 ET
|
Virtus Diversified REIT
Virtus Diversified REIT announces pending acquisition of multi-residential apartment building in Parry Sound, solidifying long-term growth objectives.
ZyVersa Therapeutics Announces Research Published in the Peer-Reviewed Journal Diabetes Reinforcing IC 100’s Rationale for Inhibiting ASC to Attenuate Damaging Inflammation Associated with Serious Conditions Such as Obesity-related Heart Disease
October 25, 2023 06:50 ET
|
ZyVersa Therapeutics
Obesity exacerbates scarring of the heart through ASC-driven inflammasome activation in the heart leading to damaging inflammation.
Bariatric Surgeries Market Worth $27.64 Billion by 2030 - Exclusive Report by The Insight Partners
October 17, 2023 09:20 ET
|
The Insight Partners
Pune, India, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The basic principle of bariatric surgery is restricting food intake and reducing food absorption in the intestines and stomach. Bariatric surgery is...
ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammation and its Impact on Numerous Diseases
September 27, 2023 07:07 ET
|
ZyVersa Therapeutics
Mr. Glover will also serve as a judge in BioPitch competition for life science companies seeking seed and early-stage investment.ZyVersa is advancing a dynamic pipeline of drug candidates with...
Goliath Drills 66.34 Meters* of Sulphide-Rich Quartz Breccia Including Visible Gold Over 20.05 Meters* at Surebet Golden Gate Feeder Zone, Golden Triangle, B.C.
July 31, 2023 07:08 ET
|
Goliath Resources Limited
Drill Hole GD-23-157 Highlights: Visible Gold has been identified over a 20.05 meter* interval (65.78 feet*) between 119.07 and 139.12 meters inclusive of twelve (12) separate Visible Gold...
Virtus Diversified REIT Seeks to Raise $50,000,000 through New Retail Offering
July 18, 2023 14:16 ET
|
Virtus Diversified REIT
TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- Virtus Diversified Real Estate Investment Trust (REIT), a growing private REIT, is pleased to announce the release of FundServ codes AXC440, AXC441, AXC442,...
ZyVersa Therapeutics Announces a Publication in Frontiers in Medicine Showing Direct Inflammasome Activation in Children with Juvenile Idiopathic Arthritis
May 25, 2023 09:07 ET
|
ZyVersa Therapeutics
Juvenile idiopathic arthritis (“JIA”), a complex autoimmune inflammatory disorder, is the most common childhood chronic rheumatic diseaseThis is the first report documenting inflammasome activation in...